Not a good buy right now for an impatient entry: price is pressing into near-term resistance (R1 ~102.51) with RSI near overbought, while short-term pattern stats skew slightly negative.
Options are pricing very high near-term uncertainty (IV percentile ~98) ahead of earnings (2026-02-17 pre-market), which can work against a “buy now” decision if you don’t want to wait for a cleaner setup.
Wall Street remains broadly constructive (Buy/Outperform), but price targets were cut recently, signaling tempered near-term upside expectations.
Net: I would NOT chase at ~$101.9 pre-market; I’d stay on hold rather than buy today.
Technical Analysis
Trend/Momentum: MACD histogram is positive (0.365) and expanding → bullish momentum is present.
RSI: RSI(6) ~69.7 → close to overbought; upside may be limited near-term without consolidation.
Moving averages: converging MAs → indecision/transition phase rather than a clean trending tape.
Levels: Pivot ~100.11 (key line in the sand). Resistance R1 ~102.51 then R2 ~104.00; Support S1 ~97.70 then S2 ~96.21.
Price context: pre-market ~$101.94 is sitting just below R1, a spot that often leads to stall-outs/pullbacks unless volume confirms a breakout.
Volatility: 30D IV ~75.38 vs historical vol ~22.54; IV percentile ~98.41 → options are extremely expensive, reflecting a big expected move (earnings upcoming).
Activity: today’s volume vs 30D avg ~147.8% → elevated interest, consistent with event-driven positioning.
Technical Summary
Sell
4
Buy
10
Positive Catalysts
News/event: Wildfire mitigation project (Itron + Toumetis) in Southern California enhances real-time analytics adoption narrative for utilities.
Margin trend: Gross margin improved materially in 2025/Q3 (36.99%, +11.18% YoY) → operating quality improving even with softer revenue.
Analysts: Multiple firms remain constructive (Buy/Outperform) with targets still well above current price.
Earnings catalyst: QDEC 2025 earnings on 2026-02-17 (pre-market) with EPS estimate ~2.19 could re-rate the stock if results/guide beat.
Neutral/Negative Catalysts
→ higher risk of rejection/pullback than immediate clean breakout.
conflicts with call-heavy daily flow, implying uncertainty rather than a unanimous bullish setup.
Gross margin: 36.99%, +11.18% YoY → strong margin expansion is the clear bright spot.
Upcoming: QDEC 2025 earnings on 2026-02-17 (pre-market); market is already pricing a large move (very high IV).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
2026-01-27 (Oppenheimer): PT cut to $125 from $145, rating kept Outperform → still bullish, but expectations trimmed.
2026-01-05 (Johnson Rice): Upgraded to Buy from Accumulate, PT $130 → improved conviction.
2025-11-25 (Seaport): PT nudged down to $138 from $140, kept Buy → supportive stance despite dilution concerns.
Street view (pros): Belief in sustained power/utility capex and re-acceleration potential.
Street view (cons): Recent target cuts highlight nearer-term uncertainty and sensitivity to deal dilution / execution.
Wall Street analysts forecast ITRI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ITRI is 137.13 USD with a low forecast of 118 USD and a high forecast of 150 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Analyst Rating
Wall Street analysts forecast ITRI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ITRI is 137.13 USD with a low forecast of 118 USD and a high forecast of 150 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
2 Hold
0 Sell
Strong Buy
Current: 99.560
Low
118
Averages
137.13
High
150
Current: 99.560
Low
118
Averages
137.13
High
150
Oppenheimer
Noah Kaye
Outperform
downgrade
$145 -> $125
AI Analysis
2026-01-27
Reason
Oppenheimer
Noah Kaye
Price Target
$145 -> $125
AI Analysis
2026-01-27
downgrade
Outperform
Reason
Oppenheimer analyst Noah Kaye lowered the firm's price target on Itron to $125 from $145 and keeps an Outperform rating on the shares. The firm adjusted targets in the power technology group as part of a Q4 preview. While power prices are higher as overall power demand continues to grow, technology mix is starting to play a larger role in optimizing power costs with renewables mitigating price increases, the analyst tells investors in a research note.
Johnson Rice
Accumulate -> Buy
upgrade
$130
2026-01-05
Reason
Johnson Rice
Price Target
$130
2026-01-05
upgrade
Accumulate -> Buy
Reason
Johnson Rice upgraded Itron to Buy from Accumulate with a $130 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ITRI